Development of PLGA-coated β-TCP scaffolds containing VEGF for bone tissue engineering

Materials Science and Engineering C

Volumn 69, Issue , 2016, Pages 780-788

  Khojasteh, Arash ^a,b   Fahimipour, Farahnaz ^c,d   Eslaminejad, Mohamadreza Baghaban ^e   Jafarian, Mohammad ^a   Jahangir, Shahrbanoo ^e   Bastami, Farshid ^a   Tahriri, Mohammadreza ^c,d,f   Karkhaneh, Akbar ^f   Tayebi, Lobat ^c,f,g  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MARQUETTE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^f AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

PLGA; Scaffold; Tissue engineering; VEGF; TCP

Indexed keywords

BIOMATERIALS; BONE; CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; CELLS; COMPRESSIVE STRENGTH; CYTOLOGY; ENDOTHELIAL CELLS; SCAFFOLDS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

BETA TRICALCIUM PHOSPHATE; BONE TISSUE ENGINEERING; DRUG DELIVERY DEVICES; ENDOTHELIAL PROGENITOR CELLS; PLGA; POLY LACTIC-CO-GLYCOLIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

SCAFFOLDS (BIOLOGY);

BETA-TRICALCIUM PHOSPHATE; BIOCOMPATIBLE COATED MATERIAL; CALCIUM PHOSPHATE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; VASCULOTROPIN A;

ANIMAL; BONE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; COMPRESSIVE STRENGTH; CYTOLOGY; DOG; DRUG EFFECTS; DRUG RELEASE; ENDOTHELIAL PROGENITOR CELL; MESENCHYMAL STROMA CELL; PHYSIOLOGY; POROSITY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TISSUE SCAFFOLD; ULTRASTRUCTURE; X RAY DIFFRACTION;

ANIMALS; BONE AND BONES; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; COMPRESSIVE STRENGTH; DOGS; DRUG LIBERATION; ENDOTHELIAL PROGENITOR CELLS; LACTIC ACID; MESENCHYMAL STROMAL CELLS; POLYGLYCOLIC ACID; POROSITY; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; X-RAY DIFFRACTION;

EID: 84979220581     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.07.011     Document Type: Article

References (39)

1. [1] Kim, Y., Nowzari, H., Rich, S.K., Risk of prion disease transmission through bovine-derived bone substitutes: a systematic review. Clin. Implant. Dent. Relat. Res. 15:5 (2013), 645–653.
2. [2] Nojehdehian, H., Moztarzadeh, F., Baharvand, H., Mehrjerdi, N.Z., Nazarian, H, Tahriri, M., Effect of poly-l-lysine coating on retinoic acid-loaded PLGA microspheres in the differentiation of carcinoma stem cells into neural cells. Int. J. Artif. Organs. 33:10 (2010), 721–730.
3. [3] Behnia, H., Khojasteh, A., Kiani, M.T., Khoshzaban, A., Abbas, F.M., Bashtar, M., Dashti, S.G., Bone regeneration with a combination of nanocrystalline hydroxyapatite silica gel, platelet-rich growth factor, and mesenchymal stem cells: a histologic study in rabbit calvaria. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 115:2 (2013), 7–15.
4. [4] Yazdimamaghani, M., Vashaee, D., Assefa, S., Walker, K.J., Madihally, S.V., Köhler, G.A., Tayebi, L., Hybrid macroporous gelatin/bioactive-glass/nanosilver scaffolds with controlled degradation behavior and antimicrobial activity for bone tissue engineering. J. Biomed. Nanotechnol. 10:6 (2014), 911–931.
5. [5] Chevalier, E., Chulia, D., Pouget, C., Viana, M., Fabrication of porous substrates: a review of processes using pore forming agents in the biomaterial field. J. Pharm. Sci. 97:3 (2008), 1135–1154.
6. [6] Gibson, L.J., The mechanical behaviour of cancellous bone. J. Biomech. 18:5 (1985), 317–328.
7. [7] Poursamar, S., Rabiee, M., Samadikuchaksaraei, A., Tahriri, M., Karimi, M., Azami, M., Influence of the value of the pH on the preparation of nano-hydroxyapatite polyvinyl alcohol composites. J. Ceram. Process. Res. 10:5 (2009), 679–682.
8. [8] Kang, Y., Scully, A., Young, D.A., Kim, S., Tsao, H., Sen, M., et al. Enhanced mechanical performance and biological evaluation of a PLGA coated β-TCP composite scaffold for load-bearing applications. Eur. Polym. J. 47:8 (2011), 1569–1577.
9. [9] Miao, X., Tan, D.M., Li, J., Xiao, Y., Crawford, R., Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly(lactic-co-glycolic acid). Acta Biomater. 4:3 (2008), 638–645.
10. [10] Ardjomandi, N., Henrich, A., Huth, J., Klein, C., Schweizer, E., Scheideler, L., et al. Coating of β-tricalcium phosphate scaffolds—a comparison between graphene oxide and poly-lactic-co-glycolic acid. Biomed. Mater., 10(4), 2015, 045018.
11. [11] Masaeli, R., Jafarzadeh Kashi, T.S., Dinarvand, R., Tahriri, M., Shahoon, H., Raz, M., et al. Preparation, characterization and investigation of in vitro and in vivo biological properties of strontium-modified calcium phosphate cement for bone defect repair. J. Dent. Med. 28:3 (2015), 177–188.
12. [12] Xue, W., Bandyopadhyay, A., Bose, S., Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering. J. Biomed. Mater. Res. B Appl. Biomater. 91:2 (2009), 831–838.
13. [13] Yoshida, T., Miyaji, H., Otani, K., Inoue, K., Nakane, K., Nishimura, H., et al. Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2. J. Periodontal Res. 50:2 (2015), 265–273.
14. [14] Xie, X.H., Wang, X.L., Zhang, G., He, Y.X., Leng, Y., Tang, T.T., et al. Biofabrication of a PLGA–TCP-based porous bioactive bone substitute with sustained release of icaritin. J. Tissue Eng. Regen. Med. 9:8 (2015), 961–972.
15. [15] Yang, Y., Tang, G., Zhang, H., Zhao, Y., Yuan, X., Wang, M., et al. Controllable dual-release of dexamethasone and bovine serum albumin from PLGA/β-tricalcium phosphate composite scaffolds. J. Biomed. Mater. Res. B Appl. Biomater. 96:1 (2011), 139–151.
16. [16] Kwon, D.H., Bisch, F.C., Herold, R.W., Pompe, C., Bastone, P., Rodriguez, N.A., et al. Periodontal wound healing/regeneration following the application of rhGDF-5 in a β-TCP/PLGA carrier in critical-size supra-alveolar periodontal defects in dogs. J. Clin. Periodontol. 37:7 (2010), 667–674.
17. [17] Luginbuehl, V., Ruffieux, K., Hess, C., Reichardt, D., Von Rechenberg, B., Nuss, K., Controlled release of tetracycline from biodegradable β-tricalcium phosphate composites. J. Biomed. Mater. Res. B Appl. Biomater. 92:2 (2010), 341–352.
18. [18] Yu, D., Li, Q., Mu, X., Chang, T., Xiong, Z., Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology. Int. J. Oral Maxillofac. Surg. 37:10 (2008), 929–934.
19. [19] Ferrara, N., Kerbel, R.S., Angiogenesis as a therapeutic target. Nature 438:7070 (2005), 967–974.
20. [20] Davies, N., Dobner, S., Bezuidenhout, D., Schmidt, C., Beck, M., Zisch, A.H., Zilla, P., The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 29:26 (2008), 3531–3538.
21. [21] Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak, D.R., Multilineage potential of adult human mesenchymal stem cells. Science 284:5411 (1999), 143–147.
22. [22] Ramay, H.R., Zhang, M., Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods. Biomaterials 24:19 (2003), 3293–3302.
23. [23] Khojasteh, A., Fahimipour, F., Jafarian, M., Sharifi, D., Jahangir, S., Khayyatan, F., et al. Bone engineering in dog mandible: coculturing mesenchymal stem cells with endothelial progenitor cells in a composite scaffold containing vascular endothelial growth factor. J. Biomed. Mater. Res. Part B Appl. Biomater., 2016.
24. [24] Shayesteh, Y.S., Khojasteh, A., Soleimani, M., Alikhasi, M., Khoshzaban, A., Ahmadbeigi, N., Sinus augmentation using human mesenchymal stem cells loaded into a β-tricalcium phosphate/hydroxyapatite scaffold. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 106:2 (2008), 203–209.
25. [25] Horowitz, R.A., Mazor, Z., Miller, R.J., Krauser, J., Prasad, H.S., Rohrer, M.D., Clinical evaluation alveolar ridge preservation with a beta-tricalcium phosphate socket graft. Compend. Contin. Educ. Dent. 30:9 (2009), 588–590.
26. [26] Johnson, A.J.W., Herschler, B.A., A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater. 7:1 (2011), 16–30.
27. [27] Silva, E.A., Mooney, D.J., Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials 31:6 (2010), 1235–1241.
28. [28] Santo, V.E., Gomes, M.E., Mano, J.F., Reis, R.L., Controlled release strategies for bone, cartilage, and osteochondral engineering—part II: challenges on the evolution from single to multiple bioactive factor delivery. Tissue Eng. B Rev. 19:4 (2013), 327–352.
29. [29] Bluteau, G., Julien, M., Magne, D., Mallein-Gerin, F., Weiss, P., Daculsi, G., Guicheux, J., VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone 40:3 (2007), 568–576.
30. [30] Duttenhoefer, F., de Freitas, R.L., Loibl, M., Bittermann, G., Richards, R.G., Alini, M., et al. Endothelial progenitor cell fraction contained in bone marrow-derived mesenchymal stem cell populations impairs osteogenic differentiation. BioMed. Res. Int., 2015, 2015, 1.
31. [31] Loibl, M., Binder, A., Herrmann, M., Duttenhoefer, F., Richards, R.G., Nerlich, M., et al. Direct cell-cell contact between mesenchymal stem cells and endothelial progenitor cells induces a pericyte-like phenotype in vitro. BioMed. Res. Int., 2014, 2014.
32. [32] Duttenhoefer, F., de Freitas, R.L., Meury, T., Loibl, M., Benneker, L., Richards, R., et al. 3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days. Eur. Cell Mater. 26 (2013), 49–64.
33. [33] Fedorovich, N.E., Haverslag, R.T., Dhert, W.J., Alblas, J., The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng. A 16:7 (2010), 2355–2367.
34. [34] Hermann, J.S., Buser, D., Schenk, R.K., Cochran, D.L., Crestal bone changes around titanium implants. A histometric evaluation of unloaded non-submerged and submerged implants in the canine mandible. J. Periodontol. 71:9 (2000), 1412–1424.
35. [35] Fu, W.-L., Xiang, Z., Huang, F.-G., Gu, Z.-P., Yu, X.-X., Cen, S.-Q., et al. Coculture of peripheral blood-derived mesenchymal stem cells and endothelial progenitor cells on strontium-doped calcium polyphosphate scaffolds to generate vascularized engineered bone. Tissue Eng. A 21:5–6 (2014), 948–959.
36. [36] Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., Mooney, D.J., Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 20:5 (2005), 848–857.
37. [37] Bouletreau, P.J., Warren, S.M., Spector, J.A., Peled, Z.M., Gerrets, R.P., Greenwald, J.A., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast. Reconstr. Surg. 109:7 (2002), 2384–2397.
38. [38] Deckers, M.M., van Bezooijen, R.L., van der Horst, G., Hoogendam, J., van der Bent, C., Papapoulos, S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143:4 (2002), 1545–1553.
39. [39] Hofmann, A., Ritz, U., Verrier, S., Eglin, D., Alini, M., Fuchs, S., et al. The effect of human osteoblasts on proliferation and neovessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 29:31 (2008), 4217–4226.